All In MedTech

FDA Clearance Tracker · P020056-S006

NATRELLE SILICONE-FILLED BREAST IMPLANTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 6, 2008 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 6, 2008

Approved

Time to decision

140 days

Received Mar 19, 2008. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P020056-S006
Device name
NATRELLE SILICONE-FILLED BREAST IMPLANTS
Applicant
Allergan
Applicant location
Irvine, CA
Received
Mar 19, 2008
Decided
Aug 6, 2008
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P020056

Device type

Device class
Class III
Regulation
21 CFR 878.3540

Every decision under product code FTR

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY.

Source documents

Other decisions for Allergan

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.